NDT Advance Access originally published online on February 19, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nephrol Dial Transplant (2004) 19: 1237-1244
Nephrol Dial Transplant Vol. 19 No. 5 © ERA-EDTA 2004; all rights reserved
Original Article
Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen
Division of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, USA
Correspondence and offprint requests to: Michael Allon, MD, Division of Nephrology, PB, Room 226, 728 Richard Arrington Blvd., Birmingham, AL 35233, USA. Email: mdallon{at}uab.edu
Background. The standard therapy of dialysis catheter-related bacteraemia involves both systemic antibiotics and catheter replacement. We reported recently that instillation of an antibiotic lock (highly concentrated antibiotic solution) into the catheter lumen after dialysis sessions, in conjunction with systemic antibiotics, can successfully treat many episodes of catheter-related bacteraemia without requiring catheter removal. The present study evaluated whether the likelihood of achieving a cure with this protocol depends on the type of pathogen.
Methods. This was a historically controlled interventional study of an antibiotic lock protocol for the treatment of catheter-related bacteraemia. We analysed prospectively the likelihood of clinical cure (fever resolution and negative surveillance cultures) with an antibiotic lock protocol among patients with dialysis catheter-related bacteraemia. In addition, infection-free catheter survival was evaluated for up to 150 days, and compared with that observed among patients managed with routine catheter replacement.
Results. Overall, the antibiotic lock protocol was successful in 33 of 47 infected patients (70%) with catheter-related bacteraemia. The likelihood of a clinical cure was 87% for Gram-negative infections, 75% for Staphylococcus epidermidis infections, and only 40% for Staphylococcus aureus infections (P = 0.04). The median infection-free catheter survival with the antibiotic lock protocol was longer than that observed among patients with routine catheter replacement (154 vs 71 days, P = 0.02).
Conclusions. The clinical success of an antibiotic lock protocol in eradicating catheter-related bacteraemia while salvaging the catheter is highly dependent on the bacterial pathogen. Thus, the overall success rate in an individual dialysis programme will depend on the relative frequencies of different bacterial pathogens.
Keywords: antibiotic; bacteraemia; dialysis catheter; haemodialysis; infection
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Jain, M. Allon, S. Saddekni, J.-F. Barker, and I. D. Maya Does Heparin Coating Improve Patency or Reduce Infection of Tunneled Dialysis Catheters? Clin. J. Am. Soc. Nephrol., November 1, 2009; 4(11): 1787 - 1790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Ashby, A. Power, S. Singh, P. Choi, D. H. Taube, N. D. Duncan, and T. D. Cairns Bacteremia Associated with Tunneled Hemodialysis Catheters: Outcome after Attempted Salvage Clin. J. Am. Soc. Nephrol., October 1, 2009; 4(10): 1601 - 1605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P B. Bookstaver, J. C Williamson, B. K. Tucker, I. I Raad, and R. J Sherertz Activity of Novel Antibiotic Lock Solutions in a Model Against Isolates of Catheter-Related Bloodstream Infections Ann. Pharmacother., February 1, 2009; 43(2): 210 - 219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. D. Maya, J. C. O'Neal, C. J. Young, J. Barker-Finkel, and M. Allon Outcomes of Brachiocephalic Fistulas, Transposed Brachiobasilic Fistulas, and Upper Arm Grafts Clin. J. Am. Soc. Nephrol., January 1, 2009; 4(1): 86 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Onder, J. Chandar, N. Simon, R. Diaz, O. Nwobi, C. L. Abitbol, and G. Zilleruelo Comparison of tissue plasminogen activator-antibiotic locks with heparin-antibiotic locks in children with catheter-related bacteraemia Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2604 - 2610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Diskin, T. J. Stokes, L. Dansby, L. Radcliff, and T. B. Carter Catheter locks, heparin and biofilm: what is this the risk? Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2708 - 2709. [Full Text] [PDF]
|
|
|
|
|
|
A. M. Onder, J. Chandar, A. A. Billings, N. Simon, R. Diaz, D. Francoeur, C. Abitbol, and G. Zilleruelo Comparison of Early versus Late Use of Antibiotic Locks in the Treatment of Catheter-Related Bacteremia Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1048 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Labriola, R. Crott, and M. Jadoul Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1666 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Y. Lee, K. S. Ko, J.-H. Song, and K. R. Peck In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae J. Antimicrob. Chemother., October 1, 2007; 60(4): 782 - 787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Allon Current Management of Vascular Access Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 786 - 800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Aslam, B. W. Trautner, V. Ramanathan, and R. O. Darouiche Combination of Tigecycline and N-Acetylcysteine Reduces Biofilm-Embedded Bacteria on Vascular Catheters Antimicrob. Agents Chemother., April 1, 2007; 51(4): 1556 - 1558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Raad, H. Hanna, T. Dvorak, G. Chaiban, and R. Hachem Optimal Antimicrobial Catheter Lock Solution, Using Different Combinations of Minocycline, EDTA, and 25-Percent Ethanol, Rapidly Eradicates Organisms Embedded in Biofilm Antimicrob. Agents Chemother., January 1, 2007; 51(1): 78 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Mitchell, Z. Krishnasami, and M. Allon Catheter-related bacteraemia in haemodialysis patients with HIV infection Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3185 - 3188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Fortun, F. Grill, P. Martin-Davila, J. Blazquez, M. Tato, J. Sanchez-Corral, L. Garcia-San Miguel, and S. Moreno Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy J. Antimicrob. Chemother., October 1, 2006; 58(4): 816 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-Y. Lee, K. S. Ko, K. R. Peck, W. S. Oh, and J.-H. Song In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci J. Antimicrob. Chemother., June 1, 2006; 57(6): 1110 - 1115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Fernandez-Hidalgo, B. Almirante, R. Calleja, I. Ruiz, A. M. Planes, D. Rodriguez, C. Pigrau, and A. Pahissa Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study J. Antimicrob. Chemother., June 1, 2006; 57(6): 1172 - 1180. [Abstract] [Full Text] [PDF]
|
|